Anti-Mensch/Maus/Ratte BCL10 Antikörper mit von Kooperationspartnern getestetem Nachweis für WB, IHC.
Know who made it. See the evidence. Buy through one marketplace.
Anti-Human/Mouse/Rat BCL10 Antibody is a research-use antibody from Elabscience for studying BCL10 in WB, IHC workflows with listed reactivity for Human, Mouse, Rat. Specifications and supporting documents below should be reviewed when planning the experiment.
Fully tested in-house by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | IHC |
|---|---|---|---|---|---|---|---|---|
| Mensch | ||||||||
| Maus | ||||||||
| Ratte |
This product is manufactured by Elabscience and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
BCL10 encodes an immune-signalling adaptor that links CARD-domain proteins to downstream inflammatory signalling. This target record connects reviewed human BCL10 identifiers and aliases with ABMIUM catalogue products targeting BCL10.
Biological function: BCL10 has a key role in adaptive and innate immune signalling. It bridges CARD-domain-containing proteins, including CARD9, CARD11 and CARD14, to downstream pathways that activate NF-kappa-B and p38 MAP-kinase signalling, supporting expression of pro-inflammatory cytokine and chemokine genes.
